Skip to main content

Table 2 Compounds targeting Hippo pathway PTMs regulators

From: New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics

Target

Compounds

Function

ILK

QLT0267

Activation of the Hippo pathway components MST1 and LATS1 with concomitant inactivation of YAP/TAZ and TEAD-mediated transcription

Itch

Clomipramine

A clinically useful antidepressant drug. The effects in cancer cells treated with clomipramine included reduction of cell growth, and synergism with gemcitabine or mitomycin in killing cancer cells through autophagy blockade

Nedd4

Heclin

Bicyclic peptides, kills HEK293 cells growing in culture

SIAH1/2

BI-107F7

Peptide-mimetics, efficient covalent inhibitors of Siah and antagonize Siah-dependent regulation of Erk and Hif signaling in cell

BI-107F9